

To accelerate the development of treatments and a cure for LGMD2D/R3 by funding critical research, advancing clinical trials, and leveraging our global patient registry to drive progress.
Limb-Girdle Muscular Dystrophy Type 2D/R3 is a severe, progressive muscle-wasting disease caused by mutations in the alpha-sarcoglycan (SGCA) gene.
Free to join, the International LGMD2D Patient Registry is critical to driving research forward. As the only global database for LGMD2D/R3 patients, it directly supports the development of future treatments.
Your generous donation will help support awareness, advocacy, and research to find effective treatments or a cure for LGMD2D/R3.
We accept grants and donations from Fidelity Charitable, Schwab Charitable, Vanguard Charitable, and all major DAF sponsors.
Donate below or email info@lgmd2d.org for more information.

Sign up to stay up to date with updates and progress within the LGMD2D/R3 community.

There are currently no approved treatments or a cure for LGMD2D/R3. The incredible warriors fighting this disease around the world need your support. Please consider making a donation—no dollar is too small, and every dollar goes directly toward raising awareness, advocating for families, and driving the development of life-changing treatments. Join us in this critical mission. Your support truly makes a difference.
We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.